Founded in late 2018 and based in Madrid, Laboratorios Beemine (TheBeemineLab) formulates products that combine the properties of honey with medicinal CBD for wellness and pharmaceutical use. The company sells via online channels and pharmacies and has expanded into Portugal and Japan. It holds patents on its products and has built a broad product range. Beemine reported a sevenfold increase in sales in 2020 and recorded 30% revenue growth in the first six months of 2021, with a goal to triple sales in 2022. Future plans include positioning the brand as a leading CBD laboratory in the pharmaceutical channel, developing new products with strategic partners, expanding market penetration nationally and internationally, and continuing investments in technology.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2021